Susquehanna International Group, LLP Innoviva, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Innoviva, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 40,901 shares of INVA stock, worth $729,673. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,901

Holding current value

$729,673

% of portfolio

0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$16.33 - $20.04 $667,913 - $819,656	40,901 New	40,901 $789,000
Q1 2024 May 07, 2024	SELL	$14.56 - $16.78 $305,730 - $352,346	-20,998 Reduced 66.53%	10,562 $160,000
Q4 2023 Feb 14, 2024	SELL	$12.32 - $16.27 $760,821 - $1 Million	-61,755 Reduced 66.18%	31,560 $506,000
Q3 2023 Nov 14, 2023	SELL	$12.37 - $13.89 $800,103 - $898,419	-64,681 Reduced 40.94%	93,315 $1.21 Million
Q2 2023 Aug 11, 2023	BUY	$11.39 - $13.72 $1.21 Million - $1.46 Million	106,583 Added 207.31%	157,996 $2.01 Million
Q1 2023 May 16, 2023	BUY	$10.73 - $13.6 $207,904 - $263,513	19,376 Added 60.48%	51,413 $578,000
Q4 2022 Feb 14, 2023	BUY	$11.8 - $13.78 $48,934 - $57,145	4,147 Added 14.87%	32,037 $424,000
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $323,802 - $424,485	27,890 New	27,890 $324,000
Q1 2022 May 16, 2022	SELL	$15.39 - $20.25 $87,923 - $115,688	-5,713 Reduced 20.86%	21,671 $419,000
Q3 2021 Nov 15, 2021	BUY	$13.06 - $17.24 $125,297 - $165,400	9,594 Added 53.93%	27,384 $458,000
Q2 2021 Aug 11, 2021	SELL	$11.45 - $13.96 $345,435 - $421,159	-30,169 Reduced 62.91%	17,790 $239,000
Q1 2021 May 17, 2021	BUY	$11.06 - $12.87 $351,099 - $408,558	31,745 Added 195.79%	47,959 $573,000
Q4 2020 Feb 16, 2021	SELL	$9.33 - $12.48 $65 - $87	-7 Reduced 0.04%	16,214 $201,000
Q3 2020 Nov 16, 2020	SELL	$10.33 - $14.49 $2.3 Million - $3.23 Million	-222,895 Reduced 93.22%	16,221 $170,000
Q2 2020 Aug 14, 2020	SELL	$11.49 - $15.26 $87,484 - $116,189	-7,614 Reduced 3.09%	239,116 $3.34 Million
Q1 2020 May 15, 2020	BUY	$8.11 - $15.23 $1.32 Million - $2.48 Million	162,789 Added 193.93%	246,730 $2.9 Million
Q4 2019 Feb 14, 2020	SELL	$10.28 - $14.38 $189,953 - $265,713	-18,478 Reduced 18.04%	83,941 $1.19 Million
Q3 2019 Nov 14, 2019	BUY	$10.05 - $14.55 $721,579 - $1.04 Million	71,799 Added 234.48%	102,419 $1.08 Million
Q2 2019 Aug 16, 2019	BUY	$13.1 - $14.95 $120,166 - $137,136	9,173 Added 42.77%	30,620 $446,000
Q2 2018 Aug 14, 2018	BUY	$13.44 - $17.59 $288,247 - $377,252	21,447 New	21,447 $296,000

Others Institutions Holding INVA

# of Institutions

227

Shares Held

78.9M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.24B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Innoviva, Inc. Transaction History